Lung Volume Reduction Surgery

Lung volume reduction surgery (LVRS) is a surgical procedure in which sections of severely damaged lung tissue are removed. By removing the most diseased tissue (up to 30% of the lung volume), the goal is to improve the residual lung function and respiratory mechanics in patients with end-stage emphysema.

LVRS is performed through a video-assisted minimally invasive technique or through a bronchoscope using one-way valves. Studies show LVRS significantly improves quality of life, increases exercise capacity and even improves survival in carefully selected patients.

If you are interested in being evaluated for lung volume reduction surgery, please call the Lung Volume Reduction Surgery Program at (212) 305-1158 or request an appointment.

Why Choose Columbia for LVRS?

NewYork-Presbyterian/Columbia University Medical Center is the only medical center in the tri-state area designated by the National Institutes of Health as a center of excellence in LVRS for the treatment of emphysema.

Having performed LVRS for over two decades, NYP/Columbia is a major research and treatment center for lung volume reduction surgery and related airway procedures. The Lung Volume Reduction Surgery program has the experience to handle patients with the most complex conditions. The center offers all available modalities including LVRS, airway stenting, lung resection, and lung transplant. For more than eight years, the center has had a less than 1% mortality rate for surgical LVRS in patients meeting CMS approval criteria.

Call the Lung Volume Reduction Surgery Program at (212) 305-1158 or request an appointment to schedule a consultation for lung volume reduction surgery.

Who is a Candidate for LVRS?

Estimates suggest that 12 million Americans suffer have been diagnosed with chronic obstructive pulmonary disease (COPD). However, around 12 million more Americans likely have COPD, but have not yet been diagnosed. COPD is the third leading cause of death in the United States, claiming more than 120,000 lives each year (NIH). Most patients successfully manage their COPD with a combination of appropriate medical therapy, such as medication, and exercise. However in patients with end stage emphysema/COPD, these conservative treatments may no longer be sufficient, and LVRS may be recommended. Studies have shown that LVRS significantly improves quality of life, increases exercise capacity and even improves survival among patients that are good candidates for the surgery.

LVRS Course of Treatment

LVRS is indicated for patients with severe bilateral emphysema and hyperinflation, with disease located predominantly in the upper lobes of the lung. Treatment is made up of the following stages:

  • Treatment commences with a six-week program of outpatient pulmonary rehabilitation, accompanied by intensive follow-up.
  • Diagnostic tests are performed for heart function.
  • Surgery is performed, utilizing video-assisted, minimally invasive techniques in nearly all cases.
  • Patient undergoes pulmonary rehabilitation.

Bronchoscopic LVRS

We are a leading center for bronchoscopic lung volume reduction surgery. Our team has participated in several trials of valve-based bronchoscopic lung reduction (BLVR) and are an active center for FDA-approved bronchoscopic valves.

Lung Transplantation for Emphysema

Patients who are candidates for lung transplantation are referred to the NewYork-Presbyterian/Columbia University Medical Center Lung Transplant Program, one of the most active and successful in the country.

If you are interested in being evaluated for lung volume reduction surgery, please call the Lung Volume Reduction Surgery Program at (212) 305-1158 or request an appointment.


Surgeons

Mark E. Ginsburg, MD
Surgical Director, Diaphragm Center and Lung Volume Reduction Program

Joshua R Sonnett, MD
Chief, General Thoracic Surgery New York-Presbyterian/Columbia
Director, The Price Family Center for Comprehensive Chest Care, Lung and Esophageal Center

Frank D’Ovidio, MD, PhD
Surgical Director, Lung Transplant Program
Director, Ex-Vivo Lung Perfusion Program

Pulmonologists

Byron Thomashow, MD
William A. Bulman, MD
Roger Maxfield, MD
Angela DiMango, MD
Claire L Keating, MD
Keith Brenner, MD

Radiologists

Jay Leb, MD
Mary Salvatore, MD, MBA

Nursing Administration

Pat Jellen, MSN, RN
Practice Administrator

Maureen Carroll, BSN, RN
Clinician Coordinator